COVID-19 5 Years Later: The Impact on Drug Discovery

Pharmacy Times March 25, 2025
Phil Mounteney

Key Takeaways

• The pandemic necessitated unprecedented global collaboration, transforming drug discovery with AI, data sharing, and adaptive trial designs.
• AI and machine learning accelerated COVID-19 research, now integral to R&D for reducing timelines and costs.
• Non-traditional vaccine platforms, like mRNA, have expanded applications, enhancing flexibility in addressing diverse health conditions.
• Open data initiatives and public-private partnerships have become vital in tackling global health challenges and future pandemics.
• The pandemic catalyzed a shift towards a more efficient, cost-effective R&D landscape, integrating AI, automation, and multimodal approaches.

As the COVID-19 pandemic moves into an endemic phase, the major impacts on drug research, collaboration, and use of new technologies due to the spread of the virus warrant recognition.

The new normal

Today's Sponsors

Today's Sponsor